Clinical trial
A Randomized Open Label Study Comparing the Impact of Reducing the Dose of Stavudine Versus Switching to Tenofovir on Plasma Lipids, Body Composition and Mitochondrial Function in HIV-Infected Patients Receiving Antiretroviral Therapy
NCT00312832 is registered in ClinicalTrials.gov with Hospital Clinic of Barcelona as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Open Label Study Comparing the Impact of Reducing the Dose of Stavudine Versus Switching to Tenofovir on Plasma Lipids, Body Composition and Mitochondrial Function in HIV-Infected Patients Receiving Antiretroviral Therapy
- Lead sponsor
- Hospital Clinic of Barcelona
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2004
- Completion date
- February 28, 2005
- Enrollment
- 60
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hiv infections, lipoatrophy